RAFFA WEALTH MANAGEMENT, LLC’s Adial Pharmaceuticals ADIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $212 | Hold |
83
| – | – | ﹤0.01% | 1256 |
|
|
2026
Q1 | $149 | Sell |
83
-1
| -1% | -$4 | ﹤0.01% | 1223 |
|
|
2025
Q4 | $460 | Hold |
84
| – | – | ﹤0.01% | 1079 |
|
|
2025
Q3 | $740 | Hold |
84
| – | – | ﹤0.01% | 966 |
|
|
2025
Q2 | $633 | Hold |
84
| – | – | ﹤0.01% | 953 |
|
|
2025
Q1 | $1.33K | Hold |
84
| – | – | ﹤0.01% | 744 |
|
|
2024
Q4 | $2.11K | Hold |
84
| – | – | ﹤0.01% | 658 |
|
|
2024
Q3 | $2.09K | Hold |
84
| – | – | ﹤0.01% | 628 |
|
|
2024
Q2 | $2.41K | Hold |
84
| – | – | ﹤0.01% | 677 |
|
|
2024
Q1 | $2.78K | Hold |
84
| – | – | ﹤0.01% | 627 |
|
|
2023
Q4 | $3.89K | Hold |
84
| – | – | ﹤0.01% | 445 |
|
|
2023
Q3 | $5.82K | Hold |
84
| – | – | ﹤0.01% | 357 |
|
|
2023
Q2 | $10.9K | Hold |
84
| – | – | ﹤0.01% | 274 |
|
|
2023
Q1 | $18.3K | Hold |
84
| – | – | 0.01% | 225 |
|
|
2022
Q4 | $11.3K | Hold |
84
| – | – | ﹤0.01% | 268 |
|
|
2022
Q3 | $18.3K | Hold |
84
| – | – | 0.01% | 211 |
|
|
2022
Q2 | $70.1K | Buy |
84
+17
| +25% | +$15.4K | 0.03% | 111 |
|
|
2022
Q1 | $84.1K | Hold |
67
| – | – | 0.03% | 101 |
|
|
2021
Q4 | $113K | Hold |
67
| – | – | 0.04% | 84 |
|
|
2021
Q3 | $180K | Hold |
67
| – | – | 0.06% | 50 |
|
|
2021
Q2 | $107K | Hold |
67
| – | – | 0.04% | 71 |
|
|
2021
Q1 | $101K | Hold |
67
| – | – | 0.04% | 95 |
|
|
2020
Q4 | $71.1K | Hold |
67
| – | – | 0.03% | 103 |
|
|
2020
Q3 | $93.3K | Hold |
67
| – | – | 0.04% | 87 |
|
|
2020
Q2 | $58.2K | Hold |
67
| – | – | 0.02% | 104 |
|
|
2020
Q1 | $54.4K | Hold |
67
| – | – | 0.02% | 100 |
|
|
2019
Q4 | $101K | Hold |
67
| – | – | 0.04% | 94 |
|
|
2019
Q3 | $63.2K | Buy |
+67
| New | +$71.3K | 0.02% | 113 |
|
|
2019
Q2 | – | Sell |
-67
| Closed | -$144K | – | 742 |
|
|
2019
Q1 | $144K | Buy |
+67
| New | +$200K | 0.06% | 69 |
|
Other funds holding ADIL
RAFFA WEALTH MANAGEMENT, LLC's ADIL Position: Q2 2026 in Review
RAFFA WEALTH MANAGEMENT, LLC held its Adial Pharmaceuticals (ADIL) position steady in Q2 2026 at 83 shares worth $212. The position accounts for ﹤0.01% of the portfolio, ranked #1256.
RAFFA WEALTH MANAGEMENT, LLC first reported a position in ADIL in Q1 2019 and has held it in 29 quarters since. The position peaked at $180K in Q3 2021. 4 funds tracked by Wall St. Rank hold ADIL as of Q2 2026.
- RAFFA WEALTH MANAGEMENT, LLC held 83 shares of Adial Pharmaceuticals worth $212 as of Q2 2026.
- RAFFA WEALTH MANAGEMENT, LLC left its Adial Pharmaceuticals share count unchanged in Q2 2026.
- Adial Pharmaceuticals made up ﹤0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #1256 holding.
- RAFFA WEALTH MANAGEMENT, LLC first reported a position in Adial Pharmaceuticals in Q1 2019 and has held it in 29 quarters since.
- RAFFA WEALTH MANAGEMENT, LLC's Adial Pharmaceuticals position peaked at $180K in Q3 2021.
- 4 funds tracked by Wall St. Rank held Adial Pharmaceuticals as of Q2 2026.
Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.